关键词:
  首页 > 美迪医讯 > SPECT检测乳腺癌骨骼转移的效果优于FDG PET  

SPECT检测乳腺癌骨骼转移的效果优于FDG PET

【 2005-05-20 发布 】 美迪医讯
美迪网领先的医疗器械电子商务平台

根据一项最新研究发现,在鉴别已经出现骨骼转移的乳腺癌方面,骨骼单光子发射计算机断层扫描(SPECT)优于氟脱氧葡萄糖正电子发射断层扫描(FDG PET)。

FDG PET检测的原理是:肿瘤细胞葡萄糖代谢增加。SPECT检测放射活性药物(药物由临床医生给予)摄入区域。SPECT能够发现骨骼转移性肿瘤的位置,而PET做不到这一点。除此之外,骨骼SPECT能够鉴别出肿瘤细胞破坏后再生的骨骼区域。

这项研究结果发表在2005年4月的《美国X线学期刊》之上,来自日本Shizuoka癌症中心医院的科学家评估了15例乳腺癌患者的总共900份骨骼检查结果,这些患者接受了PET以及SPECT扫描检查。研究人员发现:在鉴别骨骼转移性肿瘤方面,SPECT敏感性为85%,精确性为96%;PET敏感性仅仅为17%,精确性为85%。他们还发现PET只能显示特定类型的肿瘤。

该项研究首席作者Takayoshi Uematsu医生说:“骨骼是乳腺癌转移的最常见部位。高达90%的死于乳腺癌的患者由远处骨骼转移。在乳腺癌初始部位得到治疗后,骨骼是复发频率最高的部位。”

根据研究人员的说法,确定何种影像检查技术对特定疾病的检查效果最佳,对患者的治疗是十分必要的。Uematsu医生说:“对骨骼转移瘤的早期诊断与治疗能够改善乳腺癌患者的预后,适合的影像检查方法能够帮助进行早期检测骨骼转移瘤。”

SPECT Better than FDG PET for Identifying Bone Metastases in Breast Cancer
 
Bone single photon emission computed tomography (SPECT) is superior to fluorodeoxyglucose positron emission tomography (FDG PET) for identifying breast cancer that has metastasized to an individual’s bones, according to new research.

FDG PET is a method that is based on increased metabolism of glucose in tumor cells. SPECT detects areas of radioactive agent uptake that is administered by a clinician. SPECT can demonstrate the site of bone metastases, while PET cannot. Additionally, bone SPECT can identify where bone is being regenerated after destruction by tumor cells.

In the study, which was published in the April 2005 issue of the American Journal of Roentgenology, scientists from Shizuoka Cancer Center Hospital (Japan) assessed the results in a total of 900 bones in 15 patients with breast cancer who underwent both PET and SPECT scanning.

The researchers discovered that SPECT had a sensitivity of 85% and an accuracy of 96% for identifying bone metastases, while PET had a sensitivity of only 17% and an accuracy of 85%. They also found that PET was limited in its capability to show specific types of tumors.

“Bone is the most common site of breast cancer metastasis. Up to 90% of patients dying with distant breast cancer have bone metastases. Bone is also the most frequent recurrence site after treatment for primary breast cancer,” said Takayoshi Uematsu, M.D., lead author of the study.

Determining which imaging technique is the best for a specific disorder is essential in treating the patient, according to the researchers. “Early diagnosis and treatment of bone metastases might improve outcomes in breast cancer patients, and the appropriate imaging method is able to assist in the early detection of bone metastases,” said Dr. Uematsu.

收藏本文到: Google书签 Digg Live Bookmark Yahoo书签 Facebook 百度搜藏 新浪ViVi 365Key网摘 天极网摘 和讯网摘 POCO网摘 QQ书签

  《美迪医讯》欢迎您参与新闻投稿,业务咨询: 美迪医疗网业务咨询

我要评论:《SPECT检测乳腺癌骨骼转移的效果优于FDG PET》
匿名发表 我的名字: Email: 验证码: 点击可刷新
 
    

  更多关于 SPECT,乳腺癌,骨骼转移,FDG PET  的新闻

合作支持:中华医学会 | 中华医院管理学会 | 国家食品药品监督管理家用护理器械商城 | 国药励展展览有限责任公 | 医学装备协会
刊登广告 | 友情链接 | 广告代理商加盟 | 关于美迪 | 法律声明 | 隐私保护 | 网站地图
把美迪网放进收藏夹  把美迪医疗网介绍给我的朋友  给美迪医疗网留言
美迪医疗网广告业务联系:021-51601230 产品咨询业务联系:021-51601230 传真:021-56532303    美迪医疗网业务咨询
互联网药品信息服务许可证:(沪)-经营性-2009-0003   中华人民共和国电信与信息服务业务经营许可证:(沪)B2-20090029 沪ICP备14001091号-8
 
公安备案号 31010602000199 医疗器械经营许可证: 沪静药监械经营许20210003号 第二类医疗器械经营备案凭证: 沪静药监械经营备20220042号
营业执照:统一社会信用代码91310108676284138X互联网药品信息服务资格书:(沪)-非经营性-2023-0081
消防排烟风机 华创商务网
美迪医疗网广告业务联系:021-51601230  产品咨询业务联系:021-51601230 传真:021-56532303   美迪医疗网产品咨询 本QQ仅咨询广告和会员业务,不咨询产品和药品等业务美迪医疗网推广业务咨询